Figures & data
Figure 1. Timetable of sexual thoughts/fantasy, sexual interest/desire and satisfaction with sex in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.
![Figure 1. Timetable of sexual thoughts/fantasy, sexual interest/desire and satisfaction with sex in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.](/cms/asset/3ef685b9-8470-48c5-87d0-47d0a8ef5f15/itam_a_432460_f0001_b.jpg)
Figure 2. Timetable of spontaneous morning erections, total erections, and ejacualtions in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.
![Figure 2. Timetable of spontaneous morning erections, total erections, and ejacualtions in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.](/cms/asset/4c6732f1-7a98-4f93-9530-4870c5e2bfba/itam_a_432460_f0002_b.jpg)
Figure 3. Timetable of psychological parameters (agitation, dizziness, activation, and listlessness) in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.
![Figure 3. Timetable of psychological parameters (agitation, dizziness, activation, and listlessness) in hypogonadal men receiving treatment with testosterone enanthate (TE) or testosterone undecanaote (TU) over 30 weeks.](/cms/asset/6e6d25bb-a220-480b-8797-8ffe0b631125/itam_a_432460_f0003_b.jpg)